UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 179

Sortiert nach

Safety and efficacy of raltegravir in patients with HIV‐1 and hepatitis B and/or C virus coinfection

HIV medicine, 2012-02, Vol.13 (2), p.127-131

2012

Link zum Volltext

Verfügbarkeit prüfen

Wegener granulomatosis: an analysis of 158 patients

Annals of internal medicine, 1992-03, Vol.116 (6), p.488

1992

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of Indinavir Combined with Low-Dose Ritonavir in Human Immunodeficiency Virus Type 1-Infected Children

Antimicrobial Agents and Chemotherapy, 2004-05, Vol.48 (5), p.1904-1907

2004

Link zum Volltext

Verfügbarkeit prüfen

Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis

American journal of respiratory and critical care medicine, 1995-03, Vol.151 (3 Pt 1), p.795

1995

Link zum Volltext

Verfügbarkeit prüfen

Summaries for patients. Nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1

Annals of internal medicine, 2014-10, Vol.161 (7), p.I

2014

Link zum Volltext

Verfügbarkeit prüfen

Wegener granulomatosis in children and adolescents: Clinical presentation and outcome

The Journal of pediatrics, 1993, Vol.122 (1), p.26-31

1993

Link zum Volltext

Verfügbarkeit prüfen

Surgical pathology of the lung in Wegener's granulomatosis. Review of 87 open lung biopsies from 67 patients

The American journal of surgical pathology, 1991-04, Vol.15 (4), p.315-333

1991

Link zum Volltext

Verfügbarkeit prüfen

Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor

Journal of Virology, 1996-12, Vol.70 (12), p.8270-8276

1996

Link zum Volltext

Verfügbarkeit prüfen

Indinavir did not increase the short-term risk of adverse cardiovascular events relative to nucleoside reverse transcriptase inhibitor therapy in four phase III clinical trials

AIDS (London), 2001-08, Vol.15 (12), p.1584-1586

2001

Link zum Volltext

Verfügbarkeit prüfen

A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation

Clinical infectious diseases, 2020-04, Vol.70 (8), p.1525-1533

2020

Link zum Volltext

Verfügbarkeit prüfen

Experience with surgical treatment of Takayasu's disease

Surgery, 1991-03, Vol.109 (3), p.252-258

1991

Link zum Volltext

Verfügbarkeit prüfen

Polyangiitis overlap syndrome: Classification and prospective clinical experience

The American journal of medicine, 1986-07, Vol.81 (1), p.79-85

1986

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation

American journal of transplantation, 2020-06, Vol.20 (6), p.1703-1711

2020

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Efficacy, Safety, and Tolerability of Indinavir-Based Therapy in Protease Inhibitor—Naive Adults with Advanced HIV Infection

Clinical infectious diseases, 2003-10, Vol.37 (8), p.1119-1124

2003

Link zum Volltext

Verfügbarkeit prüfen

Letermovir Prophylaxis for Cytyomegalovirus in Hematopoietic-Cell Transplantation

The New England journal of medicine, 2017-12, Vol.377 (25), p.2433

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical efficacy of raltegravir against B and non-B subtype HIV-1 in phase III clinical studies

AIDS (London), 2011-07, Vol.25 (11), p.1365-1369

2011

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide

The American journal of medicine, 1990-10, Vol.89 (4), p.403-410

1990

Link zum Volltext

Verfügbarkeit prüfen

The management of subglottic stenosis in patients with wegener's granulomatosis

The Laryngoscope, 1992-12, Vol.102 (12), p.1341-1345

1992

Link zum Volltext

Verfügbarkeit prüfen

Treatment of glucocorticoid‐resistant or relapsing takayasu arteritis with methotrexate

Arthritis and rheumatism, 1994-04, Vol.37 (4), p.578-582

1994

Link zum Volltext

Verfügbarkeit prüfen

Vasculitic Syndromes

Current opinion in rheumatology, 1993-01, Vol.5 (1), p.1-4

Leavitt, R Y

1993

Link zum Volltext

Verfügbarkeit prüfen

Buerger's disease in a young woman

The American journal of medicine, 1986-05, Vol.80 (5), p.1003-1005

1986

Link zum Volltext

Verfügbarkeit prüfen

Less common manifestations and presentations of Wegenerʼs granulomatosis

Current opinion in rheumatology, 1992-02, Vol.4 (1), p.16-22

1992

Link zum Volltext

Verfügbarkeit prüfen

The treatment of wegener's granulomatosis with glucocorticoids and methotrexate

Arthritis and rheumatism, 1992-11, Vol.35 (11), p.1322-1329

1992

Link zum Volltext

Verfügbarkeit prüfen

The American College of Rheumatology 1990 criteria for the classification of henoch‐schönlein purpura

Arthritis and rheumatism, 1990-08, Vol.33 (8), p.1114-1121

1990

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic approach to the vasculitic syndromes

The Mount Sinai journal of medicine, 1986-06, Vol.53 (6), p.440-448

1986

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 179

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(127)
Mit Volltextzugriff
(159)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety and efficacy of raltegravir in patients with HIV‐1 and hepatitis B and/or C virus coinfection

Wegener granulomatosis: an analysis of 158 patients

Pharmacokinetics of Indinavir Combined with Low-Dose Ritonavir in Human Immunodeficiency Virus Type 1-Infected Children

Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis

Summaries for patients. Nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1

Wegener granulomatosis in children and adolescents: Clinical presentation and outcome

Surgical pathology of the lung in Wegener's granulomatosis. Review of 87 open lung biopsies from 67 patients

Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor

Indinavir did not increase the short-term risk of adverse cardiovascular events relative to nucleoside reverse transcriptase inhibitor therapy in four phase III clinical trials

A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation

Experience with surgical treatment of Takayasu's disease

Polyangiitis overlap syndrome: Classification and prospective clinical experience

Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation

Long-Term Efficacy, Safety, and Tolerability of Indinavir-Based Therapy in Protease Inhibitor—Naive Adults with Advanced HIV Infection

Letermovir Prophylaxis for Cytyomegalovirus in Hematopoietic-Cell Transplantation

Clinical efficacy of raltegravir against B and non-B subtype HIV-1 in phase III clinical studies

Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide

The management of subglottic stenosis in patients with wegener's granulomatosis

Treatment of glucocorticoid‐resistant or relapsing takayasu arteritis with methotrexate

Vasculitic Syndromes

Buerger's disease in a young woman

Less common manifestations and presentations of Wegenerʼs granulomatosis

The treatment of wegener's granulomatosis with glucocorticoids and methotrexate

The American College of Rheumatology 1990 criteria for the classification of henoch‐schönlein purpura

Therapeutic approach to the vasculitic syndromes

Suchergebnisse filtern